Impacto
Downloads
Downloads per month over past year
Fernández García, Aitor and Zhou, Ying and García Alonso, Mercedes and Andrango, Henry D. and Poyales Galán, Francisco and Garzón Jiménez, Nuria (2019) Medium-term clinical outcomes following Xen45 device implantation. International Ophthalmology . ISSN 0165-5701
Preview |
PDF (Preprint)
693kB |
Official URL: https://doi.org/10.1007/s10792-019-01232-3
Abstract
Purpose: To evaluate medium-term clinical outcomes with microstent XEN® 45 Gel Stent (Allergan Dublin, Ireland) for treatment of primary open-angle glaucoma (POAG).
Material and methods: This is a retrospective, descriptive and observational study involving 93 eyes from 63 patients who had undergone POAG surgery with a XEN® 45 Gel Stent implantation and had been followed up and controlled between 12 and 36 months.
Results: IOP dropped from 18.23 ± 5.00 mmHg pre-op to 14.16 ± 2.14, 14.47 ± 2.16 and 14.63 ± 1.91 at 1, 2 and 3 years after surgery (p = 0.000, 0.000 and 0.001) consecutively. Mean number of medications dropped from 1.87 ± 0.94 preoperatively to 0.31 ± 0.69, 0.34 ± 0.63 and 1.00 ± 0.88 (p = 0.000, 0.000 and 0.017) at 12, 24 and 36 months. Mean visual field deviation values never turned out to be significant for any of the follow-up visit data. A total of 94.6% of the surgical procedures turned out to be complication-free. In one surgery, the procedure failed and 18 months later other device was implanted.
Conclusion: POAG surgical procedures with XEN® 45 Gel Stent implants are a safe and effective treatment approach.
Item Type: | Article |
---|---|
Additional Information: | Received: 7 august 2019; Accepted: 16 november 2019 |
Uncontrolled Keywords: | Glaucoma; MIGS; Xen45 |
Subjects: | Medical sciences > Medicine > Surgery Medical sciences > Medicine > Ophtalmology |
ID Code: | 58079 |
Deposited On: | 17 Dec 2019 09:50 |
Last Modified: | 17 Dec 2019 09:50 |
Origin of downloads
Repository Staff Only: item control page